- Table of Contents
For this month’s Research Spotlight, we highlight 10 new research publications from scientists whom Boster has served.
In the field of cancer immunotherapy, data from two studies point toward the anti-lymphoma and anti-bladder cancer effects exerted by ADAM10 and iDAMP inhibitors respectively. Additionally, scientists present the promising potential of CEACAM 5, PCL22-186, and lncSLCO1C1 as new biomarkers for predicting cancer cells’ radiosensitivity, cancer progression, and resistance...
Every month, we feature 10 research studies from scientists whom we have served. In our April edition of Research Spotlight, scientists focus on finding novel delivery systems to improve the poor delivery efficiency of therapeutic biomolecules.
One research paper provided new insights into how renal exosomes are aroused by β-catenin, underscoring an important therapeutic strategy for CKD. Studies highlighting the promising potential of engineered EGCG-containing nanoassemblies, microalgae-based...
The March edition of Research Spotlight presents 10 recent publications from scientists whom Boster has served.
In this edition, scientists discussed how a better understanding of the PD-L1 expression regulation can be pivotal in achieving better clinical outcomes in EBV-infected cancer patients. Another research study proposed a self-powered smart patch that serves as a reservoir of chemokine-/neural-directing exosomes, offering a serviceable strategy to stimulate skin neuro-engineering and regeneration of tissues and organs.
In terms of bone diseases, one paper revealed the potential role of Calca, an osteoblast-derived ProCT in the bone microenvironment that is required to limit bone resorption during iPTH. Several development strategies in the fields of nanotechnology and biomaterials were also achieved through the construction of cell-responsive peptide assemblies and nanorod-like coating with ions doping.
Explore below for a closer look at these research discoveries!
In our last edition of Research Spotlight this year, we're happy to feature 10 recent publications from scientists whom Boster has served.
Among the studies, scientists investigate the mechanisms of m6a reader for colorectal cancer, the anti-metastatic roles of dsRNA mimics, and the effects of USP12 on breast cancer angiogenesis.
In addition, scientists explore Vitamin D3's antioxidative stress ability as well as the lungfish cocoon's antimicrobial functions. Researchers also develop pitavastatin-loaded multilayer films that enhance osseointegration of metal implants.
Scroll down to find out more about these discoveries!
Our November edition of Research Spotlight highlights 10 research studies that provide deeper insights on the biological functions of several key biomarkers and their clinical translational potential.
Two studies reveal new insights for diabetes treatment by investigating the functions of PGRMC1 and an m6A reader protein for insulin metabolism and delayed diabetic wound healing respectively.
Scientists also perform bioinformatics and immunological analysis of several regulatory...
In our March edition of Research Spotlight, we present 10 latest research papers from scientists whom Boster has served.
Scientists explore the roles of various pathways associated with tumor development, and how they may emerge as new therapeutic targets for tumor metastasis. Several research studies also reveal the active role of gut microbiota in immunity and disease progressions as well as the effect of several compounds on the functionality and ecology of gut microbiome.
Take a look below to learn more about these new research findings.
We are delighted to announce Boster Bio has been named a winner of the 2021 Bioz Stars Award for Antibodies! We’re proud to be supporting scientists worldwide to advance their research since 1993.
Bioz Stars Awards are based on real-world measured successful product usage from over 33 million peer-reviewed scientific articles analyzed by Bioz’s patented AI technology. Winners are selected using data that generates objective product ratings and recommendations. Bioz’s AI platform exami...
The February edition of Research Spotlight provides 10 recent research discoveries from scientists whom Boster has served, which include new insights on the interactions between nanoparticles and human health as well as the underlying mechanisms.
The pathology-improvement effects of siRNA-based drugs on lung disorders, trichostatin A on Alzheimer’s disease, and propofol on microglial phagocytosis were also explored.
Scroll down to find out more about each featured publication.
The December edition of Research Spotlight highlights 10 recent research discoveries from scientists whom Boster has served.
In these studies, the effects of several key proteins and their signaling pathways were explored in correlation to the progression and activation of cancer cells, diabetic nephropathy, inflammation, and brain injury.
The role of polysulfides as potential tumor suppressors and regulators might represent an alternative therapeutic candidate for the management of diabetic nephropathy. Additionally, several promising potential therapeutic strategies for enhanced immunotherapy, such as enhanced drug delivery systems, ultrasound-guided platelet-rich plasma injection, and the role of mechanical cues in vascular biology were also investigated.
Scroll down to find more information about these new scientific discoveries.
In our November edition of Research Spotlight, we feature 10 recently published research papers from scientists whom Boster has served.
This month’s selected research publications investigate how several cells and mediators regulate the development of fibrotic diseases, cancer, inflammatory responses, diabetes, allergy, endometriosis, and anxiety.
Among the studies, scientists propose the underlying mechanisms of how endothelin receptor antagonists may serve as a therapeutic strategy for fibrotic diseases. The role of PRMT5 in laryngeal tumor carcinogenesis is also explored.
Discover more details about these new scientific discoveries below.